Linda Llewelyn is CPO at Health Catalyst, Inc. (HCAT). They have made 16 open-market trades across 1 company since 2020, most recently 2026-06-01.
CIK 0001780878
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HCAT | 321,132 | $556K |
Shares reported on the most recent Form 4, priced at the 2026-06-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HCAT | SELL · 10b5-1 | 2025-02-18 | 2025-02-20 | $5.43 | $35K | -17.7% | -18.8% | -31.9% |
| HCAT | SELL · 10b5-1 | 2025-01-15 | 2025-01-17 | $5.80 | $37K | +0.4% | -1.8% | -30.2% |
| HCAT | SELL · 10b5-1 | 2024-12-16 | 2024-12-18 | $7.88 | $102K | -5.1% | -26.3% | -40.3% |
| HCAT | SELL · 10b5-1 | 2024-11-15 | 2024-11-18 | $8.50 | $12K | +19.8% | -1.4% | -26.7% |
| HCAT | SELL · 10b5-1 | 2024-10-15 | 2024-10-17 | $8.16 | $11K | -8.7% | -13.0% | -33.5% |
| HCAT | SELL · 10b5-1 | 2024-09-16 | 2024-09-18 | $8.43 | $11K | -9.6% | -3.8% | -15.0% |
| HCAT | SELL · 10b5-1 | 2024-08-15 | 2024-08-16 | $6.57 | $9K | +0.1% | +25.1% | +24.1% |
| HCAT | SELL · 10b5-1 | 2024-07-15 | 2024-07-17 | $6.51 | $8K | +6.5% | -6.4% | +18.0% |
| HCAT | SELL · 10b5-1 | 2024-06-17 | 2024-06-20 | $6.37 | $8K | +0.7% | +21.9% | +44.2% |
| HCAT | SELL · 10b5-1 | 2024-05-15 | 2024-05-20 | $7.00 | $14K | -3.6% | -12.2% | -0.6% |
| HCAT | SELL · 10b5-1 | 2024-04-15 | 2024-04-17 | $6.11 | $12K | +13.0% | +23.9% | +31.0% |
| HCAT | SELL · 10b5-1 | 2024-03-15 | 2024-03-19 | $7.80 | $16K | -7.6% | -27.7% | -18.5% |
| HCAT | SELL · 10b5-1 | 2024-02-15 | 2024-02-20 | $9.77 | $32K | -16.4% | -15.9% | -28.3% |
| HCAT | SELL · 10b5-1 | 2024-01-16 | 2024-01-18 | $10.83 | $34K | +4.5% | -1.3% | -42.8% |
| HCAT | SELL · 10b5-1 | 2023-12-15 | 2023-12-19 | $8.83 | $28K | -1.7% | +5.9% | -18.0% |
| HCAT | SELL · 10b5-1 | 2023-11-15 | 2023-11-17 | $8.25 | $10K | -7.7% | +10.5% | +28.9% |
| HCAT | SELL · 10b5-1 | 2023-10-16 | 2023-10-20 | $8.33 | $10K | -6.6% | +0.1% | +27.0% |
| HCAT | SELL · 10b5-1 | 2023-09-15 | 2023-09-19 | $11.01 | $13K | -2.2% | -21.3% | -16.9% |
| HCAT | SELL · 10b5-1 | 2023-08-22 | 2023-08-24 | $11.90 | $9K | +1.1% | -16.5% | -34.5% |
| HCAT | SELL · 10b5-1 | 2023-02-15 | 2023-02-17 | $13.82 | $9K | +6.4% | -12.3% | -17.8% |
| HCAT | SELL · 10b5-1 | 2023-01-17 | 2023-01-19 | $12.12 | $8K | +7.1% | +0.4% | -0.4% |
| HCAT | SELL · 10b5-1 | 2022-12-15 | 2022-12-19 | $11.00 | $7K | +4.5% | +22.3% | +12.2% |
| HCAT | SELL · 10b5-1 | 2022-11-15 | 2022-11-17 | $10.82 | $7K | +4.1% | +2.7% | +43.4% |
| HCAT | SELL · 10b5-1 | 2022-10-18 | 2022-10-20 | $9.53 | $6K | -1.5% | +0.4% | +35.5% |
| HCAT | SELL · 10b5-1 | 2022-09-15 | 2022-09-19 | $10.99 | $7K | -0.4% | -9.3% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.